Matches in Wikidata for { <http://www.wikidata.org/entity/Q53535574> ?p ?o ?g. }
- Q53535574 description "2015 nî lūn-bûn" @default.
- Q53535574 description "2015年の論文" @default.
- Q53535574 description "2015年学术文章" @default.
- Q53535574 description "2015年学术文章" @default.
- Q53535574 description "2015年学术文章" @default.
- Q53535574 description "2015年学术文章" @default.
- Q53535574 description "2015年学术文章" @default.
- Q53535574 description "2015年学术文章" @default.
- Q53535574 description "2015年學術文章" @default.
- Q53535574 description "2015年學術文章" @default.
- Q53535574 description "2015年學術文章" @default.
- Q53535574 description "2015年學術文章" @default.
- Q53535574 description "2015年學術文章" @default.
- Q53535574 description "2015년 논문" @default.
- Q53535574 description "article científic" @default.
- Q53535574 description "article scientific" @default.
- Q53535574 description "article scientifique" @default.
- Q53535574 description "articol științific" @default.
- Q53535574 description "articolo scientifico" @default.
- Q53535574 description "artigo científico" @default.
- Q53535574 description "artigo científico" @default.
- Q53535574 description "artigo científico" @default.
- Q53535574 description "artikel ilmiah" @default.
- Q53535574 description "artikull shkencor" @default.
- Q53535574 description "artikulong pang-agham" @default.
- Q53535574 description "artykuł naukowy" @default.
- Q53535574 description "artículo científico publicado en 2015" @default.
- Q53535574 description "artículu científicu" @default.
- Q53535574 description "bilimsel makale" @default.
- Q53535574 description "bài báo khoa học" @default.
- Q53535574 description "naučni članak" @default.
- Q53535574 description "scienca artikolo" @default.
- Q53535574 description "scientific article published on 16 April 2015" @default.
- Q53535574 description "scientific article published on 16 April 2015" @default.
- Q53535574 description "scientific article published on 16 April 2015" @default.
- Q53535574 description "teaduslik artikkel" @default.
- Q53535574 description "tieteellinen artikkeli" @default.
- Q53535574 description "tudományos cikk" @default.
- Q53535574 description "vedecký článok" @default.
- Q53535574 description "vetenskaplig artikel" @default.
- Q53535574 description "videnskabelig artikel" @default.
- Q53535574 description "vitenskapelig artikkel" @default.
- Q53535574 description "vitskapeleg artikkel" @default.
- Q53535574 description "vědecký článek" @default.
- Q53535574 description "wetenschappelijk artikel" @default.
- Q53535574 description "wissenschaftlicher Artikel" @default.
- Q53535574 description "επιστημονικό άρθρο" @default.
- Q53535574 description "мақолаи илмӣ" @default.
- Q53535574 description "наукова стаття, опублікована у квітні 2015" @default.
- Q53535574 description "научна статия" @default.
- Q53535574 description "научная статья" @default.
- Q53535574 description "научни чланак" @default.
- Q53535574 description "научни чланак" @default.
- Q53535574 description "מאמר מדעי" @default.
- Q53535574 description "مقالة علمية نشرت في 16 أبريل 2015" @default.
- Q53535574 description "১৬ এপ্রিল ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53535574 description "บทความทางวิทยาศาสตร์" @default.
- Q53535574 description "სამეცნიერო სტატია" @default.
- Q53535574 name "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08." @default.
- Q53535574 name "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08." @default.
- Q53535574 type Item @default.
- Q53535574 label "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08." @default.
- Q53535574 label "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08." @default.
- Q53535574 prefLabel "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08." @default.
- Q53535574 prefLabel "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08." @default.
- Q53535574 P1433 Q53535574-B4F6DB30-17EF-4B34-9126-DE29BC52ECEF @default.
- Q53535574 P1476 Q53535574-AA6EE0F2-6036-472F-8AB9-6165F8128CCC @default.
- Q53535574 P2093 Q53535574-3BA6B780-144B-4D16-A556-51B669BDA03A @default.
- Q53535574 P2093 Q53535574-3C4C7DCB-D0F2-45F3-AEED-87694E9FEFB8 @default.
- Q53535574 P2093 Q53535574-4022F20D-13D7-4139-9AFF-CB18B346AF52 @default.
- Q53535574 P2093 Q53535574-4D5B9905-98CC-435A-AA94-235F38FDDD03 @default.
- Q53535574 P2093 Q53535574-879564EE-E817-4C1E-B912-7C89252EA545 @default.
- Q53535574 P2093 Q53535574-8FEE61F1-40D7-4BB3-964E-A5D558C821B4 @default.
- Q53535574 P2093 Q53535574-BB00E034-933C-40EA-B9A1-A245B124B5EB @default.
- Q53535574 P2093 Q53535574-C13F9E36-AECA-4CE8-97BA-B094867E47F3 @default.
- Q53535574 P2093 Q53535574-C490E31B-D58E-46E4-94CE-A290B629F222 @default.
- Q53535574 P2093 Q53535574-CBE03E04-827B-4B3F-A113-A866FFC623CB @default.
- Q53535574 P2093 Q53535574-E7C4C04D-85C6-4A66-931F-69659B75CE87 @default.
- Q53535574 P304 Q53535574-B9B3D744-DBA1-43FE-9B4A-819C77E8C0F2 @default.
- Q53535574 P31 Q53535574-1347EBAE-D9CE-478B-8B2F-4AC44BE38411 @default.
- Q53535574 P356 Q53535574-B00EE18E-F169-4C01-B228-A769E3598DE9 @default.
- Q53535574 P433 Q53535574-F9F3F323-8C70-4DCF-B653-07E472611583 @default.
- Q53535574 P478 Q53535574-5CEF9F49-3A93-40E2-BF6C-C1D915FCF4ED @default.
- Q53535574 P50 Q53535574-274D33F9-C935-4989-B629-14692A198AF8 @default.
- Q53535574 P50 Q53535574-F62C7E99-BA3F-48A1-B83C-7BEE48822319 @default.
- Q53535574 P577 Q53535574-2537D311-58F7-4AC3-AA33-D911C536752D @default.
- Q53535574 P5875 Q53535574-F9E20D61-BABE-4BFE-9D39-BCFB23B816B7 @default.
- Q53535574 P698 Q53535574-54203550-D1C9-45AC-8914-060E873B959B @default.
- Q53535574 P921 Q53535574-358611EC-474E-4F99-875D-7B8358FCC277 @default.
- Q53535574 P921 Q53535574-52D05E34-7373-4C00-AC50-54B12DB1B1A5 @default.
- Q53535574 P921 Q53535574-6985DF52-79E4-4487-91E6-E58B524F6695 @default.
- Q53535574 P921 Q53535574-BDD5980F-1373-4440-9931-1783699D34E0 @default.
- Q53535574 P356 J.EJCA.2015.03.016 @default.
- Q53535574 P698 25892646 @default.
- Q53535574 P1433 Q332260 @default.
- Q53535574 P1476 "Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08" @default.
- Q53535574 P2093 "Catherine Berset" @default.
- Q53535574 P2093 "Christine Biaggi Rudolf" @default.
- Q53535574 P2093 "Christoph Mamot" @default.
- Q53535574 P2093 "Christoph Rochlitz" @default.